Mar 11, 2025 / 12:00PM GMT
Operator
Good day, and welcome to the Legend Biotech fourth quarter and full year 2024 earnings call. (Operator Instructions) As a reminder, this call may be recorded.
I would now like to turn the call over to Caroline Paul, Associate Director of Investor Relations. Please go ahead.
Caroline Paul - Nanjing Legend Biotechnology Co Ltd - Associate Director of Investor Relations
Good morning. This is Caroline Paul, Associate Director of Investor Relations at Legend Biotech. Thank you for joining our conference call today to review our fourth quarter of 2024 performance. Prior to this call, we issued a press release announcing our financial results for the quarter. You can find the press release on our IR website at legendbiotech.com. Joining me on today's call are Ying Huang, the company's Chief Executive Officer; and Jessie Yeung, the company's Interim Chief Financial Officer.
Following the prepared remarks, we will open up the call for Q&A. We have our President of CARVYKTI, Alan Bash, President of R&D, Guowei Fang; and Chief Medical Officer,
Q4 2024 Legend Biotech Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
